Phenibut

What is Phenibut?

Phenibut is a synthetic molecule: the neurotransmitter GABA with a phenyl ring attached, which lets it cross into the brain in a way GABA itself cannot. It was developed in the Soviet Union in the 1960s and has been used there as a prescription medicine for anxiety, tension, insomnia and some neurological complaints. It reportedly travelled in Soviet cosmonaut medical kits, a fact repeated endlessly in marketing copy and which tells you nothing about how well it works.

Outside the former Soviet bloc, phenibut has no medical approval. It is sold online as a "supplement" or "nootropic" in some countries, banned outright in others (including Australia, the UK as a controlled substance since 2019, and several European states), and treated by regulators such as the US FDA as an unapproved drug that does not qualify as a dietary ingredient.

The honest summary is that phenibut behaves like a drug with real central nervous system activity — it is a GABA-B receptor agonist, chemically related to baclofen — and it carries drug-level risks. What separates it from most entries in a natural-health library is not that it does nothing, but that it does something with a short leash: effects fade with repeated use within days to weeks, and stopping after regular use can cause a genuinely dangerous withdrawal state that has led to hospital admissions and intensive care.

How does Phenibut work?

Phenibut is an agonist at GABA-B receptors, the same target as the prescription muscle relaxant baclofen, which produces sedation, muscle relaxation and reduced anxiety-like behaviour. At higher concentrations it also has weak activity at GABA-A receptors, and the R-enantiomer blocks the α2δ subunit of voltage-gated calcium channels — the target of gabapentin and pregabalin. Because GABA-B receptors downregulate quickly with continuous stimulation, tolerance develops fast and the adapted brain becomes hyperexcitable when the drug is removed. That receptor adaptation is the mechanism behind both the fading benefit and the severe withdrawal.

What forms does Phenibut come in?

Two chemical forms circulate. Phenibut HCl is the salt used in Russian pharmaceutical tablets and most bulk powder; it is strongly acidic and sour, and taking the loose powder dry can irritate the mouth and stomach. Phenibut FAA (free amino acid) is less acidic, less water-soluble, and roughly 10–20% more potent by weight, which is a common cause of accidental overdose when someone switches from HCl to FAA using the same scoop. Bulk powders bought online are frequently unverified for identity and purity, and eyeballing doses without a milligram scale is a documented route to overdose. Prescription products in Russia, Latvia and Ukraine (Noofen, Anvifen, Citrocard) are standardised tablets or capsules, typically 100–250 mg.

Where it comes from:

Phenibut was synthesised at the Herzen Leningrad Pedagogical Institute in the early 1960s by a team including Vsevolod Perekalin, and was studied and introduced clinically in the Soviet Union under names such as Phenigama and later Phenibut and Noofen. It was used for anxiety, asthenia, stuttering, vestibular disorders and childhood tics, and remains a registered prescription medicine in Russia, Belarus, Ukraine, Latvia and Kazakhstan. From the late 2000s it spread through Western nootropic forums and online supplement sellers. The subsequent decade produced a steady stream of poison-centre reports and case series on intoxication, dependence and withdrawal, prompting bans or scheduling in Australia, the UK, Hungary, Lithuania, Finland, Italy and elsewhere, and FDA warning letters to US sellers.

What does Phenibut help with?

• Anxiety: Anxiety is the main reason people take phenibut, and the acute anxiolytic effect is real and reported consistently by users — it is a GABA-B agonist, and GABA-B agonism reduces anxiety-like states. What is missing is any modern randomised controlled trial in an anxiety disorder. The Russian clinical literature is decades old, small, and not reported to current standards. Just as important, the effect does not hold: tolerance develops within days to a few weeks of regular use, so people escalate the dose, and stopping then produces rebound anxiety worse than the original problem.
• Social anxiety: Phenibut is widely traded online as a "social lubricant" for parties and public speaking, described as producing talkativeness and lowered inhibition. There are no controlled trials in social anxiety disorder at all. The pattern of intermittent use to get through social situations is exactly the pattern that shifts into daily use, because the effect lasts most of a day and the come-down is unpleasant. Established treatments for social anxiety — CBT and SSRIs — have far better evidence and no withdrawal seizure risk.
• Insomnia: Sedation is one of phenibut's more reliable acute effects, and it has been used in Russia for sleep complaints. There are no adequate modern trials of sleep architecture or sleep outcomes. In practice the long half-life means next-day grogginess is common, tolerance to the sedative effect is fast, and withdrawal insomnia after regular use is described in case reports as severe and prolonged, lasting weeks. Using it as a nightly sleep aid is the highest-risk way to take it.
• Alcohol withdrawal symptoms (Russian clinical use only): Because it acts on GABA systems, phenibut has been used in Russian practice as an adjunct in alcohol withdrawal and in post-withdrawal anxiety. This use has not been validated in controlled trials outside that setting, and it is self-evidently a substitution of one dependence-forming GABAergic agent for another. Alcohol withdrawal can be fatal and requires medical supervision with established drugs, usually benzodiazepines. This is not something to attempt with an online-purchased powder.
• Vestibular disorders and motion sickness (Russian clinical use only): Older Russian sources describe phenibut for vertigo, Ménière-type symptoms and motion sickness, and there is animal work on vestibular compensation. The human data behind this indication are sparse and largely inaccessible or unreplicated. For motion sickness and vertigo there are well-studied options — antihistamines, betahistine where indicated, vestibular rehabilitation — with vastly better safety profiles.
• Stuttering and tics in children (historical Russian use): Historical Soviet paediatric use included stuttering, tics and enuresis. This should be read as a record of past prescribing practice, not as evidence of effect. There is no acceptable modern trial support, and giving a dependence-forming GABA-B agonist to a child is not defensible outside a supervised medical system that has evaluated it. Do not use phenibut in children.

What can Phenibut help prevent?

• Nothing. Phenibut has no established preventive use, and regular use creates a new problem — dependence — rather than preventing one.

Which foods are rich in Phenibut?

Phenibut is a synthetic molecule and is not present in any food. Plain GABA sold as a supplement is a different compound that crosses into the brain poorly, and fermented foods that contain GABA (kimchi, some yoghurts and teas) will not reproduce phenibut's effects — do not treat them as equivalents. If the underlying issue is anxiety or poor sleep, the dietary levers with actual support are unremarkable but real: cut alcohol, which worsens rebound anxiety and fragments sleep; keep caffeine to the morning and cap the total; eat regularly to avoid blood-sugar dips that mimic anxiety symptoms; get magnesium from leafy greens, nuts and legumes, and omega-3s from oily fish. Foods and drinks to limit: alcohol above all, since combining it with phenibut is genuinely dangerous as well as counterproductive, plus late-day caffeine and energy drinks.

What are the side effects of Phenibut?

• Sedation, drowsiness and impaired coordination: driving and operating machinery are unsafe
• Dizziness, nausea and vomiting
• Headache and a hangover-like fatigue the following day
• Slurred speech, memory gaps and confusion at higher doses
• Rapid tolerance: the same dose stops working within days to weeks
• Physical dependence, with compulsive redosing and dose escalation
• Withdrawal syndrome on stopping: severe anxiety, agitation, insomnia, tremor, palpitations, hallucinations, delirium and seizures — this has required intensive care in reported cases
• Dangerous additive sedation and respiratory depression when combined with alcohol, opioids, benzodiazepines or gabapentinoids
• Overdose presenting as deep unconsciousness, low body temperature, agitated delirium on waking, and occasionally seizures

Good to know:

Phenibut's side-effect profile is that of a central nervous system drug, not a nutrient. The acute effects are mostly manageable; the serious problem is dependence and withdrawal, which is documented in numerous published case reports and poison-centre series worldwide. Withdrawal after regular use can be life-threatening and should never be attempted alone. Because most phenibut is bought as unregulated bulk powder, dose accuracy and product identity are additional real hazards.

How much Phenibut should you take?

• Recommended daily: No dose is recommended here for self-treatment. For context only: prescription products in Russia are typically 250 mg tablets, used at 250–750 mg per day in divided doses for short courses of a few weeks, under medical supervision. The gram-level doses common in online use are well above that range and are where the intoxication and dependence case reports come from. Phenibut FAA powder is more potent by weight than the HCl salt, and swapping between them by volume has caused overdoses.
• Best time of day: Not applicable — this is not a supplement to schedule. If it is being used at all, understand that the effect peaks 2–4 hours after dosing and can persist 12–24 hours, so evening use frequently causes next-day sedation.
• With or without food: The HCl powder is strongly acidic and irritating; if taken, it is dissolved in water and taken with food to reduce stomach upset. Never take it dry.
• Time to effect: Onset is slow for a sedative — commonly 2–4 hours. This delay leads people to redose before the first dose has peaked, which is a recognised route to accidental overdose.
• How long to take it: There is no safe long-term regimen. Tolerance is reported within days to weeks, and physical dependence has been described after only a few weeks of daily use. Anyone taking it regularly should not stop abruptly — withdrawal can include seizures and psychosis, and tapering should be done with medical help, sometimes with baclofen or a benzodiazepine under supervision.